Potential biomarkers in the fibrosis progression of nonalcoholic steatohepatitis (NASH)

被引：0
|
作者：
Z. Wang
Z. Zhao
Y. Xia
Z. Cai
C. Wang
Y. Shen
R. Liu
H. Qin
J. Jia
G. Yuan
机构：
[1] Affiliated Hospital of Jiangsu University,Department of Endocrinology
来源：
Journal of Endocrinological Investigation | 2022年 / 45卷
关键词：
WGCNA; Single-cell RNA-seq; NASH; Fibrosis; HCC;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1379 / 1392
页数：13
相关论文
共 50 条
  • [21] Insulin Resistance, Reason or Consequence Nonalcoholic Steatohepatitis (NASH)
    Akbari, Hamed
    Vakili, Sina
    Aria, Hamid
    Taghadosi, Roholah
    Alavi, Seyed Ali
    RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES, 2015, 6 (03): : 1861 - 1865
  • [22] A new method to induce nonalcoholic steatohepatitis (NASH) in mice
    Savari, Feryal
    Mard, Seyyed Ali
    Badavi, Mohammad
    Rezaie, Anahita
    Gharib-Naseri, Mohammad Kazem
    BMC GASTROENTEROLOGY, 2019, 19 (1)
  • [23] ADIPOHORMONES AS PROGNOSTIC MARKERS IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH)
    Krawczyk, K.
    Szczesniak, P.
    Kumor, A.
    Jasinska, A.
    Omulecka, A.
    Pietruczuk, M.
    Orszulak-Michalak, D.
    Sporny, S.
    Malecka-Panas, E.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2009, 60 : 71 - 75
  • [24] A new method to induce nonalcoholic steatohepatitis (NASH) in mice
    Feryal Savari
    Seyyed Ali Mard
    Mohammad Badavi
    Anahita Rezaie
    Mohammad Kazem Gharib-Naseri
    BMC Gastroenterology, 19
  • [25] Serum biomarkers in nonalcoholic steatohepatitis: value for assessing drug effects?
    Heeringa, Marten
    Hastings, Ann
    Yamazaki, Shunji
    de Koning, Paul
    BIOMARKERS IN MEDICINE, 2012, 6 (06) : 743 - 757
  • [26] A short report on NGM282/aldafermin for the treatment of nonalcoholic steatohepatitis (NASH)
    Roberts, Stuart K.
    Majeed, Ammar
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2021, 25 (10) : 889 - 895
  • [27] Diagnostic and interventional circulating biomarkers in nonalcoholic steatohepatitis
    Tincopa, Monica A.
    ENDOCRINOLOGY DIABETES & METABOLISM, 2020, 3 (04)
  • [28] Soluble Endoglin as a Potential Biomarker of Nonalcoholic Steatohepatitis (NASH) Development, Participating in Aggravation of NASH-Related Changes in Mouse Liver
    Sa, Ivone Cristina Igreja
    Tripska, Katarina
    Hroch, Milos
    Hyspler, Radomir
    Ticha, Alena
    Lastuvkova, Hana
    Schreiberova, Jolana
    Dolezelova, Eva
    Eissazadeh, Samira
    Vitverova, Barbora
    Najmanova, Iveta
    Vasinova, Martina
    Pericacho, Miguel
    Micuda, Stanislav
    Nachtigal, Petr
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (23) : 1 - 19
  • [29] A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer
    Tsuchida, Takuma
    Lee, Youngmin A.
    Fujiwara, Naoto
    Ybanez, Maria
    Allen, Brittany
    Martins, Sebastiao
    Fiel, M. Isabel
    Goossens, Nicolas
    Chou, Hsin-I.
    Hoshida, Yujin
    Friedman, Scott L.
    JOURNAL OF HEPATOLOGY, 2018, 69 (02) : 385 - 395
  • [30] Effects of green tea catechins on nonalcoholic steatohepatitis (NASH) patients
    Fukuzawa, Yoshitaka
    Kapoor, Mahendra P.
    Yamasaki, Koji
    Okubo, Tsutomu
    Hotta, Yoshihiro
    Juneja, Lekh Raj
    JOURNAL OF FUNCTIONAL FOODS, 2014, 9 : 48 - 59
12345